Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
deals
europe blog main
2
×
europe top stories
life sciences
m&a
national blog main
national top stories
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
biopharma
bluerock therapeutics
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
clinical trials
covid-19
crispr
deerfield management
detroit blog main
detroit top stories
duchenne
durvalumab
editas medicine
fda
forty seven
fred hutch
general atlantic
What
deal
2
×
acquisitions
announced
approval
betting
billion
bio
biopharma
ceo
collabs
covid
daniel
duchenne
fda
gene
gilead
gilead’s
help
historic
introduce
ipo
medicine
medicines
month
o’day
plans
puts
recently
rna
roche
roundup
sarepta
sciences
second
swiss
therapeutics
therapy
transformative
won
years
Language
unset
2
×
Current search:
deal
×
unset
×
" europe blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal